Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Strides Arcolab Gets USFDA Nod to Sell Cancer Drug in US

      Onco Therapies Ltd, a wholly owned subsidiary of Strides Arcolab, has received the US Food and Drug Administration (USFDA) approval to sell the generic version of cisplatin, an anti-cancer injection, in the US market. Cisplatin is a chemotherapy drug used to treat various types of cancers.

      Strides Arcolab Ltd is a major Indian pharmaceutical company that manufactures a wide range of pharmaceutical products, including softgel capsules, sterile injectables and others. Strides Arcolab said in a statement that it has received the approval to market cisplatin injection in the strength of 1 mg/ml in 50ml and 100ml multiple dose vials. The company also reported that the approval of cisplatin has come at just the right time when the US drug market is facing shortage of the chemotherapy drugs.

      "Cisplatin is part of the oncology portfolio licensed to Pfizer in January 2010 for the US market," Strides Arcolab said in a release. The company also added that it expects to launch the product shortly in the US market. According to the data from the India's largest pharmaceutical intelligence and market research company, the annual sale of generic cisplatin in the US is 10 million USD.


      Share this Article!

    Back to top^